2024 Q2 Form 10-Q Financial Statement

#000182252324000019 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $18.38M $14.76M $16.83M
YoY Change 14.19% -12.32% -3.18%
Cost Of Revenue $3.985M $3.463M $3.704M
YoY Change 20.27% -6.52% -3.72%
Gross Profit $14.40M $11.20M $13.10M
YoY Change 12.62% -14.5% -3.23%
Gross Profit Margin 78.32% 75.9% 77.84%
Selling, General & Admin $2.437M $2.552M $2.708M
YoY Change 49.88% -5.74% 6.86%
% of Gross Profit 16.93% 22.78% 20.67%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $6.422M $6.015M $6.412M
YoY Change 30.02% -6.19% 0.48%
Operating Profit $7.977M $5.187M $6.690M
YoY Change 1.66% -22.47% -6.53%
Interest Expense $1.573M $1.603M $1.668M
YoY Change -0.16% -3.9% -1.88%
% of Operating Profit 19.72% 30.91% 24.94%
Other Income/Expense, Net $6.190M -$4.932M -$702.4K
YoY Change 285.4% 602.09% -22.39%
Pretax Income $16.73M $104.2K $10.20M
YoY Change 36.0% -98.98% 0.2%
Income Tax $286.0K $158.4K $175.1K
% Of Pretax Income 1.71% 151.91% 1.72%
Net Earnings $16.45M -$54.12K $10.03M
YoY Change 35.52% -100.54% -1.35%
Net Earnings / Revenue 89.46% -0.37% 59.56%
Basic Earnings Per Share $0.80 -$0.01 $0.49
Diluted Earnings Per Share $0.80 -$0.01 $0.49
COMMON SHARES
Basic Shares Outstanding 20.67M shares 20.67M shares 20.49M shares
Diluted Shares Outstanding 20.44M shares 20.41M shares 20.49M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $170.3M $82.30M $80.61M
YoY Change 107.48% 2.1% 26.71%
Cash & Equivalents $170.3M $82.30M $80.61M
Short-Term Investments
Other Short-Term Assets $691.8K $532.8K $420.2K
YoY Change -0.87% 26.82% -30.46%
Inventory
Prepaid Expenses
Receivables $0.00 $5.690M
Other Receivables $0.00 $0.00
Total Short-Term Assets $171.0M $88.52M $81.03M
YoY Change 106.57% 9.25% 26.17%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $287.0M $387.9M $366.8M
YoY Change -22.68% 5.75% -5.91%
TOTAL ASSETS
Total Short-Term Assets $171.0M $88.52M $81.03M
Total Long-Term Assets $287.0M $387.9M $366.8M
Total Assets $458.0M $476.4M $447.8M
YoY Change 0.88% 6.38% -1.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.436M $1.045M $1.611M
YoY Change 11.83% -35.13% -0.28%
Accrued Expenses $5.758M $6.627M $8.698M
YoY Change -12.44% -23.8% 11.93%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $55.24M $77.61M $21.80M
YoY Change 114.98% 255.97% 7.57%
LONG-TERM LIABILITIES
Long-Term Debt $88.31M $88.16M $87.57M
YoY Change 0.68% 0.68% -9.41%
Other Long-Term Liabilities $157.3K $9.140K $585.8K
YoY Change -39.29% -98.44% -6.89%
Total Long-Term Liabilities $88.47M $88.17M $88.15M
YoY Change 0.56% 0.02% -9.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $55.24M $77.61M $21.80M
Total Long-Term Liabilities $88.47M $88.17M $88.15M
Total Liabilities $143.7M $165.8M $110.0M
YoY Change 26.43% 50.78% -6.47%
SHAREHOLDERS EQUITY
Retained Earnings -$36.51M -$39.93M -$11.41M
YoY Change 301.13% 249.95%
Common Stock $206.7K $206.7K $204.9K
YoY Change 1.02% 0.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $314.3M $310.6M $337.9M
YoY Change
Total Liabilities & Shareholders Equity $458.0M $476.4M $447.8M
YoY Change 0.88% 6.38% -1.37%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $16.45M -$54.12K $10.03M
YoY Change 35.52% -100.54% -1.35%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $10.32M $6.373M $4.383M
YoY Change 100.54% 45.4% -6.06%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $113.0M -$53.88M $14.99M
YoY Change 1305.95% -459.41% -149.89%
Cash From Investing Activities $113.0M -$53.88M $14.99M
YoY Change 1305.95% -459.41% -149.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -35.28M $8.180M -$79.14M
YoY Change 201.35% -110.34% 290.85%
NET CHANGE
Cash From Operating Activities 10.32M $6.373M $4.383M
Cash From Investing Activities 113.0M -$53.88M $14.99M
Cash From Financing Activities -35.28M $8.180M -$79.14M
Net Change In Cash 88.00M -$39.33M -$59.77M
YoY Change 5871.54% -34.2% 30.98%
FREE CASH FLOW
Cash From Operating Activities $10.32M $6.373M $4.383M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
125 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20667094 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20457697 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-54116 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
10025274 usd
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
125 shares
CY2023Q1 afcg Severance Costs Period To Receive Base Salary
SeveranceCostsPeriodToReceiveBaseSalary
P12M
CY2023Q1 afcg Severance Cobra Premiums Paid Period
SeveranceCOBRAPremiumsPaidPeriod
P12M
CY2024Q1 afcg Share Based Compensation Arrangement By Share Based Payment Award Expiration Period Extension
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriodExtension
P1Y
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20667094 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20457697 shares
CY2024Q1 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
1603163 usd
CY2023Q1 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
1668160 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14757897 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16832326 usd
CY2024Q1 afcg Accrued Exchange Fee Rebate
AccruedExchangeFeeRebate
374803 usd
CY2023Q1 afcg Accrued Exchange Fee Rebate
AccruedExchangeFeeRebate
478645 usd
CY2024Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3462762 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3704219 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1052396 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2006135 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
543222 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
280578 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
956568 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
420898 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
6014948 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
6411830 usd
CY2024Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
4931674 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
702426 usd
CY2024Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-93338 usd
CY2023Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-26384 usd
CY2024Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1986381 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-3613693 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-1477691 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
104244 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10200376 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
158360 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
175102 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-54116 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
10025274 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20393875 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20303797 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20405187 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20489163 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
320052225 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
543222 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.48
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
9920205 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-54116 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
310621126 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
339059369 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
268658 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.56
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
11473971 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
10025274 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
337879330 usd
CY2024Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
4931674 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
702426 usd
CY2024Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-93338 usd
CY2023Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-26384 usd
CY2024Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1986381 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-3613693 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-1477691 usd
CY2024Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1927782 usd
CY2023Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1236946 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
543222 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
268658 usd
CY2024Q1 afcg Payment In Kind Interest
PaymentInKindInterest
1600987 usd
CY2023Q1 afcg Payment In Kind Interest
PaymentInKindInterest
4503746 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-55 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
640023 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-1409750 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-50923 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1431 usd
CY2024Q1 afcg Increase Decrease In Interest Reserve
IncreaseDecreaseInInterestReserve
0 usd
CY2023Q1 afcg Increase Decrease In Interest Reserve
IncreaseDecreaseInInterestReserve
3010610 usd
CY2024Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1307888 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1180416 usd
CY2024Q1 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-8964 usd
CY2023Q1 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-187515 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-523535 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-757625 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
333886 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
776510 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6372548 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4382627 usd
CY2024Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
84190779 usd
CY2023Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
1523332 usd
CY2024Q1 us-gaap Proceeds From Sale Of Loans Held For Investment
ProceedsFromSaleOfLoansHeldForInvestment
1796042 usd
CY2023Q1 us-gaap Proceeds From Sale Of Loans Held For Investment
ProceedsFromSaleOfLoansHeldForInvestment
13693481 usd
CY2024Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
28513871 usd
CY2023Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
2821467 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-53880866 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
14991616 usd
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
60000000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
CY2024Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
42000000 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
60000000 usd
CY2024Q1 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
9819695 usd
CY2023Q1 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
11403840 usd
CY2024Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0 usd
CY2023Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
7737500 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8180305 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-79141340 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-39328013 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-59767097 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
121626453 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
140372841 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
82298440 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
80605744 usd
CY2024Q1 afcg Interest Reserve Withheld From Funding Of Loan
InterestReserveWithheldFromFundingOfLoan
0 usd
CY2023Q1 afcg Interest Reserve Withheld From Funding Of Loan
InterestReserveWithheldFromFundingOfLoan
1500000 usd
CY2024Q1 afcg Original Issue Discount Withheld From Funding Of Loans
OriginalIssueDiscountWithheldFromFundingOfLoans
1641888 usd
CY2023Q1 afcg Original Issue Discount Withheld From Funding Of Loans
OriginalIssueDiscountWithheldFromFundingOfLoans
0 usd
CY2024Q1 afcg Dividends Declared But Not Yet Paid
DividendsDeclaredButNotYetPaid
9920205 usd
CY2023Q1 afcg Dividends Declared But Not Yet Paid
DividendsDeclaredButNotYetPaid
11473971 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
42000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
290834 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
124733 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates in the Preparation of Financial Statements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant estimates include the valuation of loans held for investment at fair value and current expected credit losses (“CECL”).</span></div>
CY2023 afcg Number Of Loans Held For Investments In Portfolio
NumberOfLoansHeldForInvestmentsInPortfolio
2 loan
CY2024Q1 afcg Number Of Loans Held For Investments In Portfolio
NumberOfLoansHeldForInvestmentsInPortfolio
2 loan
CY2024Q1 afcg Loans Held For Investment At Fair Value Aggregate Commitments
LoansHeldForInvestmentAtFairValueAggregateCommitments
94200000 usd
CY2023Q4 afcg Loans Held For Investment At Fair Value Aggregate Commitments
LoansHeldForInvestmentAtFairValueAggregateCommitments
94200000 usd
CY2024Q1 afcg Loans Held For Investment Outstanding Principal Amount
LoansHeldForInvestmentOutstandingPrincipalAmount
68600000 usd
CY2023Q4 afcg Loans Held For Investment Outstanding Principal Amount
LoansHeldForInvestmentOutstandingPrincipalAmount
71900000 usd
CY2024Q1 afcg Proceeds From Principal Repayments Of Loans Held For Investment At Fair Value
ProceedsFromPrincipalRepaymentsOfLoansHeldForInvestmentAtFairValue
4000000 usd
CY2024Q1 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
54977282 usd
CY2024Q1 afcg Loans Held For Investment Cost
LoansHeldForInvestmentCost
68514273 usd
CY2024Q1 afcg Loans Held For Investment Outstanding Principal Amount
LoansHeldForInvestmentOutstandingPrincipalAmount
68625288 usd
CY2024Q1 afcg Loans Held For Investment At Fair Value Weighted Average Remaining Life
LoansHeldForInvestmentAtFairValueWeightedAverageRemainingLife
P0Y1M6D
CY2023Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
61720705 usd
CY2023Q4 afcg Loans Held For Investment Cost
LoansHeldForInvestmentCost
71644003 usd
CY2023Q4 afcg Loans Held For Investment Outstanding Principal Amount
LoansHeldForInvestmentOutstandingPrincipalAmount
71883402 usd
CY2023Q1 afcg Loans Held For Investment At Fair Value Weighted Average Remaining Life
LoansHeldForInvestmentAtFairValueWeightedAverageRemainingLife
P0Y4M24D
CY2023Q4 afcg Loans Held For Investment Outstanding Principal Amount
LoansHeldForInvestmentOutstandingPrincipalAmount
71883402 usd
CY2023Q4 afcg Loans Held For Investment At Fair Value Original Issue Discount
LoansHeldForInvestmentAtFairValueOriginalIssueDiscount
239399 usd
CY2023Q4 afcg Loans Held For Investment At Fair Value Unrealized Gains Losses
LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses
-9923298 usd
CY2023Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
61720705 usd
CY2024Q1 afcg Loans Held For Investment At Fair Value Unrealized Gains Losses Change In Unrealized Gains Losses On Loans At Fair Value Net
LoansHeldForInvestmentAtFairValueUnrealizedGainsLossesChangeInUnrealizedGainsLossesOnLoansAtFairValueNet
-3613693 usd
CY2024Q1 afcg Loans Held For Investment At Fair Value Change In Unrealized Gains Losses On Loans At Fair Value Net
LoansHeldForInvestmentAtFairValueChangeInUnrealizedGainsLossesOnLoansAtFairValueNet
-3613693 usd
CY2024Q1 afcg Loans Held For Investment At Fair Value Original Issue Discount Accretion Of Original Issue Discount
LoansHeldForInvestmentAtFairValueOriginalIssueDiscountAccretionOfOriginalIssueDiscount
128384 usd
CY2024Q1 afcg Loans Held For Investment At Fair Value Accretion Of Original Issue Discount
LoansHeldForInvestmentAtFairValueAccretionOfOriginalIssueDiscount
128384 usd
CY2024Q1 afcg Proceeds From Principal Repayments Of Loans Held For Investment At Fair Value Outstanding Principal
ProceedsFromPrincipalRepaymentsOfLoansHeldForInvestmentAtFairValueOutstandingPrincipal
4003945 usd
CY2024Q1 afcg Proceeds From Principal Repayments Of Loans Held For Investment At Fair Value
ProceedsFromPrincipalRepaymentsOfLoansHeldForInvestmentAtFairValue
4003945 usd
CY2024Q1 afcg Loans Held For Investment At Fair Value Outstanding Principal Payment In Kind Interest
LoansHeldForInvestmentAtFairValueOutstandingPrincipalPaymentInKindInterest
745831 usd
CY2024Q1 afcg Loans Held For Investment At Fair Value Payment In Kind Interest
LoansHeldForInvestmentAtFairValuePaymentInKindInterest
745831 usd
CY2024Q1 afcg Loans Held For Investment Outstanding Principal Amount
LoansHeldForInvestmentOutstandingPrincipalAmount
68625288 usd
CY2024Q1 afcg Loans Held For Investment At Fair Value Original Issue Discount
LoansHeldForInvestmentAtFairValueOriginalIssueDiscount
111015 usd
CY2024Q1 afcg Loans Held For Investment At Fair Value Unrealized Gains Losses
LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses
-13536991 usd
CY2024Q1 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
54977282 usd
CY2024Q1 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
54977282 usd
CY2024Q1 afcg Loans Held For Investment Cost
LoansHeldForInvestmentCost
68514273 usd
CY2024Q1 afcg Loans Held For Investment Outstanding Principal Amount
LoansHeldForInvestmentOutstandingPrincipalAmount
68625288 usd
CY2024Q1 afcg Number Of Loans Held For Investments
NumberOfLoansHeldForInvestments
12 loan
CY2023 afcg Number Of Loans Held For Investments
NumberOfLoansHeldForInvestments
9 loan
CY2024Q1 afcg Loans Held For Investment At Carrying Value Aggregate Commitments
LoansHeldForInvestmentAtCarryingValueAggregateCommitments
402600000 usd
CY2023Q4 afcg Loans Held For Investment At Carrying Value Aggregate Commitments
LoansHeldForInvestmentAtCarryingValueAggregateCommitments
333100000 usd
CY2024Q1 us-gaap Receivable With Imputed Interest Face Amount
ReceivableWithImputedInterestFaceAmount
370600000 usd
CY2023Q4 us-gaap Receivable With Imputed Interest Face Amount
ReceivableWithImputedInterestFaceAmount
314400000 usd
CY2024Q1 afcg Loans Held For Investment At Carrying Value Outstanding Principal New Fundings
LoansHeldForInvestmentAtCarryingValueOutstandingPrincipalNewFundings
85800000 usd
CY2024Q1 afcg Receivable With Imputed Interest Loan Repayments And Amortization Payments
ReceivableWithImputedInterestLoanRepaymentsAndAmortizationPayments
24500000 usd
CY2024Q1 afcg Receivable With Imputed Interest Sale Of Loans Face Amount
ReceivableWithImputedInterestSaleOfLoansFaceAmount
6000000 usd
CY2024Q1 afcg Percentage Of Loans Held With Floating Interest Rates
PercentageOfLoansHeldWithFloatingInterestRates
0.61
CY2023Q4 afcg Percentage Of Loans Held With Floating Interest Rates
PercentageOfLoansHeldWithFloatingInterestRates
0.84
CY2024Q1 us-gaap Receivable With Imputed Interest Face Amount
ReceivableWithImputedInterestFaceAmount
370554826 usd
CY2024Q1 us-gaap Receivable With Imputed Interest Discount
ReceivableWithImputedInterestDiscount
12702359 usd
CY2024Q1 afcg Loans Held For Investment Carrying Value
LoansHeldForInvestmentCarryingValue
357852467 usd
CY2024Q1 afcg Loans Held For Investment Weighted Average Remaining Life
LoansHeldForInvestmentWeightedAverageRemainingLife
P2Y1M6D
CY2023Q4 us-gaap Receivable With Imputed Interest Face Amount
ReceivableWithImputedInterestFaceAmount
314376929 usd
CY2023Q4 us-gaap Receivable With Imputed Interest Discount
ReceivableWithImputedInterestDiscount
13111531 usd
CY2023Q4 afcg Loans Held For Investment Carrying Value
LoansHeldForInvestmentCarryingValue
301265398 usd
CY2023 afcg Loans Held For Investment Weighted Average Remaining Life
LoansHeldForInvestmentWeightedAverageRemainingLife
P2Y2M12D
CY2023Q4 us-gaap Receivable With Imputed Interest Face Amount
ReceivableWithImputedInterestFaceAmount
314376929 usd
CY2023Q4 us-gaap Receivable With Imputed Interest Discount
ReceivableWithImputedInterestDiscount
13111531 usd
CY2023Q4 afcg Loans Held For Investment Carrying Value
LoansHeldForInvestmentCarryingValue
301265398 usd
CY2024Q1 afcg Receivable With Imputed Interest New Funding Face Amount
ReceivableWithImputedInterestNewFundingFaceAmount
85832667 usd
CY2024Q1 afcg Receivable With Imputed Interest Discount On New Funding
ReceivableWithImputedInterestDiscountOnNewFunding
1641888 usd
CY2024Q1 afcg Receivable With Imputed Interest New Funding Net Amount
ReceivableWithImputedInterestNewFundingNetAmount
84190779 usd
CY2024Q1 afcg Receivable With Accretion Of Original Issue Discount Premium
ReceivableWithAccretionOfOriginalIssueDiscountPremium
1799398 usd
CY2024Q1 afcg Accretion Of Original Issue Discount Net Amount
AccretionOfOriginalIssueDiscountNetAmount
1799398 usd
CY2024Q1 afcg Receivable With Imputed Interest Loan Repayments Face Amount
ReceivableWithImputedInterestLoanRepaymentsFaceAmount
23290973 usd
CY2024Q1 afcg Receivable With Imputed Interest Loan Repayments
ReceivableWithImputedInterestLoanRepayments
23290973 usd
CY2024Q1 afcg Receivable With Imputed Interest Sale Of Loans Face Amount
ReceivableWithImputedInterestSaleOfLoansFaceAmount
6000000 usd
CY2024Q1 afcg Receivable With Imputed Interest Sale Of Loans Original Issue Discount
ReceivableWithImputedInterestSaleOfLoansOriginalIssueDiscount
251662 usd
CY2024Q1 afcg Receivable With Sale Of Loans Net Amount
ReceivableWithSaleOfLoansNetAmount
5748338 usd
CY2024Q1 afcg Receivable With Paid In Kind Interest Face Amount
ReceivableWithPaidInKindInterestFaceAmount
855156 usd
CY2024Q1 afcg Receivable With Paid In Kind Interest Net Amount
ReceivableWithPaidInKindInterestNetAmount
855156 usd
CY2024Q1 afcg Receivable With Imputed Interest Amortization Payments
ReceivableWithImputedInterestAmortizationPayments
1218953 usd
CY2024Q1 afcg Receivable With Imputed Interest Loan Amortization Payments
ReceivableWithImputedInterestLoanAmortizationPayments
1218953 usd
CY2024Q1 us-gaap Receivable With Imputed Interest Face Amount
ReceivableWithImputedInterestFaceAmount
370554826 usd
CY2024Q1 us-gaap Receivable With Imputed Interest Discount
ReceivableWithImputedInterestDiscount
12702359 usd
CY2024Q1 afcg Loans Held For Investment Carrying Value
LoansHeldForInvestmentCarryingValue
357852467 usd
CY2024Q1 us-gaap Receivable With Imputed Interest Face Amount
ReceivableWithImputedInterestFaceAmount
370554826 usd
CY2024Q1 us-gaap Receivable With Imputed Interest Discount
ReceivableWithImputedInterestDiscount
12702359 usd
CY2024Q1 afcg Loans Held For Investment Carrying Value
LoansHeldForInvestmentCarryingValue
357852467 usd
CY2024Q1 afcg Number Of Portfolio Loans
NumberOfPortfolioLoans
1 loan
CY2023Q4 afcg Number Of Portfolio Loans
NumberOfPortfolioLoans
1 loan
CY2024Q1 afcg Loans Receivable At Carrying Value Aggregate Commitments
LoansReceivableAtCarryingValueAggregateCommitments
4000000 usd
CY2023Q4 afcg Loans Receivable At Carrying Value Aggregate Commitments
LoansReceivableAtCarryingValueAggregateCommitments
4000000 usd
CY2024Q1 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
2000000 usd
CY2023Q4 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
2000000 usd
CY2023Q4 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
2041744 usd
CY2023Q4 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
1686 usd
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
2040058 usd
CY2024Q1 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
0 usd
CY2024Q1 afcg Payments On Loans Receivable Carrying Value
PaymentsOnLoansReceivableCarryingValue
0 usd
CY2024Q1 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
2041744 usd
CY2024Q1 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
1686 usd
CY2024Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
2040058 usd
CY2024Q1 us-gaap Interest Receivable
InterestReceivable
4362274 usd
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
3715995 usd
CY2024Q1 afcg Contractual Obligation Loan Commitments
ContractualObligationLoanCommitments
500793726 usd
CY2024Q1 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
79068238 usd
CY2024Q1 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
27433654 usd
CY2024Q1 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
67163051 usd
CY2024Q1 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
180583470 usd
CY2024Q1 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
5644112 usd
CY2024Q1 afcg Loans Held For Investment And Financing Receivable Before Allowance For Credit Loss
LoansHeldForInvestmentAndFinancingReceivableBeforeAllowanceForCreditLoss
359892525 usd
CY2024Q1 afcg Interest Receivables
InterestReceivables
3788106 usd
CY2023Q4 afcg Interest Receivables
InterestReceivables
2680188 usd
CY2024Q1 afcg Payment In Kind Receivable
PaymentInKindReceivable
414863 usd
CY2023Q4 afcg Payment In Kind Receivable
PaymentInKindReceivable
1009974 usd
CY2024Q1 afcg Unused Fees Receivable
UnusedFeesReceivable
159305 usd
CY2023Q4 afcg Unused Fees Receivable
UnusedFeesReceivable
25833 usd
CY2024Q1 afcg Number Of Loans Included In Loan Funded Interest Reserve
NumberOfLoansIncludedInLoanFundedInterestReserve
0 loan
CY2023 afcg Number Of Loans Included In Loan Funded Interest Reserve
NumberOfLoansIncludedInLoanFundedInterestReserve
0 loan
CY2024Q1 afcg Reserves Disbursed Interest
ReservesDisbursedInterest
0 usd
CY2023Q1 afcg Reserves Disbursed Interest
ReservesDisbursedInterest
3200000 usd
CY2023Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
0 usd
CY2022Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
3200944 usd
CY2024Q1 afcg New Reserves Interest
NewReservesInterest
0 usd
CY2023Q1 afcg New Reserves Interest
NewReservesInterest
1716985 usd
CY2024Q1 afcg Reserves Disbursed Interest
ReservesDisbursedInterest
0 usd
CY2023Q1 afcg Reserves Disbursed Interest
ReservesDisbursedInterest
3227595 usd
CY2024Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
0 usd
CY2023Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1690334 usd
CY2022Q2 afcg Line Of Credit Facility Accordion Feature Increase Limit
LineOfCreditFacilityAccordionFeatureIncreaseLimit
100000000.0 usd
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
1349887 usd
CY2024Q1 us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
0 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
253276 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
1603163 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
1435417 usd
CY2023Q1 us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
35833 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
196910 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
1668160 usd
CY2023Q4 afcg Contractual Obligation Loan Commitments
ContractualObligationLoanCommitments
431239913 usd
CY2024Q1 afcg Contractual Obligation Drawn Loan Commitments
ContractualObligationDrawnLoanCommitments
486213058 usd
CY2023Q4 afcg Contractual Obligation Drawn Loan Commitments
ContractualObligationDrawnLoanCommitments
421239913 usd
CY2024Q1 us-gaap Contractual Obligation
ContractualObligation
14580668 usd
CY2023Q4 us-gaap Contractual Obligation
ContractualObligation
10000000 usd
CY2023Q1 afcg Severance Cobra Premiums Paid Percentage
SeveranceCOBRAPremiumsPaidPercentage
1
CY2023Q1 afcg Share Based Compensation Arrangement By Share Based Payment Award Accelerated Vesting Number Of Tranches
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingNumberOfTranches
1 tranche
CY2024Q1 us-gaap Severance Costs1
SeveranceCosts1
0 usd
CY2023Q1 us-gaap Severance Costs1
SeveranceCosts1
700000 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
20000000 usd
CY2024Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
161879 shares
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
206304 shares
CY2024Q1 afcg Share Based Compensation Arrangement By Share Based Payment Award Options Vested Cumulative Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedCumulativeNumberOfShares
2212753 shares
CY2023Q4 afcg Share Based Compensation Arrangement By Share Based Payment Award Options Vested Cumulative Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedCumulativeNumberOfShares
2168328 shares
CY2024Q1 afcg Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Cumulative
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesCumulative
5511 shares
CY2023Q4 afcg Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Cumulative
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesCumulative
5511 shares
CY2024Q1 afcg Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Cumulative Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedCumulativeNumberOfShares
200169 shares
CY2023Q4 afcg Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Cumulative Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedCumulativeNumberOfShares
200169 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2168952 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2168952 shares
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
500000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
300000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2168952 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.74
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2168952 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.74
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y7D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2123596 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
17.72
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y3D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3100000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y4M9D
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-54116 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
10025274 usd
CY2024Q1 us-gaap Dividends
Dividends
57126 usd
CY2023Q1 us-gaap Dividends
Dividends
35472 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-111242 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-111242 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
9989802 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
9989802 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20393875 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20303797 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
11312 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
185366 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20405187 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20489163 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2240089 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2280372 shares
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000 usd
CY2024Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
158360 usd
CY2023Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
174832 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
0 usd
CY2023Q1 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
270 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
158360 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
175102 usd
CY2024Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
105300 usd
CY2024Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
53100 usd
CY2023Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
131500 usd
CY2023Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
43300 usd
CY2024Q1 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
0 usd
CY2024Q1 afcg Exercise Tax As A Percentage Of Undistributed Ordinary Income And Net Capital Gains
ExerciseTaxAsAPercentageOfUndistributedOrdinaryIncomeAndNetCapitalGains
0.04
CY2024Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2024Q1 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
54977282 usd
CY2024Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
54977282 usd
CY2023Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
61720705 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
61720705 usd
CY2024Q1 afcg Incentive Compensation
IncentiveCompensation
2500000 usd
CY2023Q1 afcg Incentive Compensation
IncentiveCompensation
2800000 usd
CY2024Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
4245081 usd
CY2023Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
4790246 usd

Files In Submission

Name View Source Status
afcg-20240331_def.xml Edgar Link unprocessable
0001822523-24-000019-index-headers.html Edgar Link pending
0001822523-24-000019-index.html Edgar Link pending
0001822523-24-000019.txt Edgar Link pending
0001822523-24-000019-xbrl.zip Edgar Link pending
afcg-20240331.htm Edgar Link pending
afcg-20240331.xsd Edgar Link pending
afcg-20240331xex311.htm Edgar Link pending
afcg-20240331xex312.htm Edgar Link pending
afcg-20240331xex321.htm Edgar Link pending
afcg-20240331xex322.htm Edgar Link pending
afcg-20240331_g1.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
afcg-20240331_cal.xml Edgar Link unprocessable
afcg-20240331_lab.xml Edgar Link unprocessable
afcg-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
afcg-20240331_htm.xml Edgar Link completed
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending